Macular amyloidosis (MA) commonly occurs in populations of the Middle East, Asia, and Central and South America. Women, especially those aged 20 to 50 years, are more likely than men to present with ...

Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.

Amyloidosis is the deposition of extracellular amyloid protein throughout the body with impaired functioning of the affected organs. When isolated to the skin, it is termed primary cutaneous ...